Cegedim SA (EPA:ALCGM)
France · Delayed Price · Currency is EUR 10.24
-0.22 (-2.10%)
Jul 13, 2026, 5:39 PM CET
Cegedim Market Cap
Cegedim has a market cap or net worth of €140.6 million as of July 13, 2026. Its market cap has decreased by -2.82% in one year.
Market Cap
140.60M
Enterprise Value
389.90M
Revenue
649.17M
Ranking
n/a
PE Ratio
14.99
Stock Price
€10.24
Market Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 140.60M, an increase of 23.50%. That is a compound annual growth rate of 0.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 140.60M | -24.63% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 91.49B |
| EssilorLuxottica Société anonyme | 78.80B |
| Sartorius Stedim Biotech | 17.83B |
| Ipsen | 13.36B |
| Cellectis | 188.04M |
| Median Technologies | 176.51M |
| Bastide Le Confort Médical | 173.07M |
| Innate Pharma | 147.69M |